On June 4, 2025, Cogent Biosciences, Inc. held its Annual Meeting where stockholders approved key amendments to the company's Certificate of Incorporation, including officer liability exculpation, and electing directors. The meeting saw 113,856,454 shares available for voting, with significant support for proposals.